1-7 of 7
Wing H. Tong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Toxicity of Very Prolonged Pegasparaginase and Erwinia Asparaginase Courses in Relation to Asparaginase Activity Levels with a Special Focus on Dyslipidemia

Wing H. Tong, MD PhD, Rob Pieters, Hester A. de Groot-Kruseman, PhD, Wim C.J. Hop, PhD, Joachim Boos, MD PhD, Wim J Tissing, MD PhD, Inge M. van der Sluis, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2256.
https://doi.org/10.1182/blood.V124.21.2256.2256
Published: 2014
Journal Articles

A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia

Clinical Trials & Observations
Wing H. Tong, Rob Pieters, Gertjan J. L. Kaspers, D. Maroeska W. M. te Loo, Marc B. Bierings, Cor van den Bos, Wouter J. W. Kollen, Wim C. J. Hop, Claudia Lanvers-Kaminsky, Mary V. Relling, Wim J. E. Tissing, Inge M. van der Sluis
Journal: Blood
Blood (2014) 123 (13): 2026–2033.
https://doi.org/10.1182/blood-2013-10-534347
Published: 2014
Includes: Supplemental data
Journal Articles

Should We Use a Desensitization Protocol In Acute Lymphoblastic Leukemia Patients With Silent Inactivation Of Pegasparaginase?

Wing H. Tong, MD, Rob Pieters, Wim J Tissing, MD, PhD, Inge M. van der Sluis, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1434.
https://doi.org/10.1182/blood.V122.21.1434.1434
Published: 2013
Journal Articles

A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia

Wing H. Tong, MD, Rob Pieters, Gertjan Kaspers, MD, PhD, Maroeska D.W.M. te Loo, MD, PhD, Marc Bierings, Cor van den Bos, MD, PhD, Wouter J.W. Kollen, MD, PhD, Wim C.J. Hop, PhD, Joachim Boos, MD, PhD, Mary V. Relling, PharmD, Hans Juergen Kuehnel, MD, Wim J Tissing, MD, PhD, Inge M. van der Sluis, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2634.
https://doi.org/10.1182/blood.V122.21.2634.2634
Published: 2013
Journal Articles

Disturbed CXCR4/CXCL12 Axis In Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia

Lieke C.J. van den Berk, PhD, Arian van der Veer, MD, Marieke E. Willemse, MSc, Myrte J.G.A. Theeuwes, BSc, Mirjam W. Luijendijk, PhD, Wing H. Tong, MD, Inge M. van der Sluis, MD, PhD, Rob Pieters, Monique L. den Boer, PhD
Journal: Blood
Blood (2013) 122 (21): 2643.
https://doi.org/10.1182/blood.V122.21.2643.2643
Published: 2013
Journal Articles

Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia with Pegasparaginase and Erwinia Asparaginase: The Impact of Expensive Chemotherapy

Wing H. Tong, MD, Inge M. van der Sluis, MD, PhD, Cathelijne Alleman, MSc, Raphaele RL van Litsenburg, MD, PhD, Gertjan Kaspers, MD, PhD, Rob Pieters, MD, PhD, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2012) 120 (21): 4227.
https://doi.org/10.1182/blood.V120.21.4227.4227
Published: 2012
Journal Articles

The Bone Marrow Niche of Patients with Acute Lymphoblastic Leukemia Produces No Increased Asparagine Levels In Vivo That May Lead to Clinical Asparaginase Resistance

Wing H. Tong, MD, Rob Pieters, MD, PhD, Wim C.J. Hop, PhD, Claudia Lanvers-Kaminsky, PhD, Joachim Boos, MD, PhD, Inge M. van der Sluis, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1505.
https://doi.org/10.1182/blood.V118.21.1505.1505
Published: 2011